Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125527111 | 12552711 | 1 | I | 20160217 | 20160614 | 20160713 | 20160713 | PER | US-009507513-1606USA006748 | MERCK | 65.14 | YR | M | Y | 0.00000 | 20160713 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125527111 | 12552711 | 1 | PS | PRINIVIL | LISINOPRIL | 1 | Oral | 10 MG, QD | Y | 19558 | 10 | MG | TABLET | QD | |||||
| 125527111 | 12552711 | 2 | SS | PRINIVIL | LISINOPRIL | 1 | Oral | UNK | Y | 19558 | TABLET | ||||||||
| 125527111 | 12552711 | 3 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, QD | U | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125527111 | 12552711 | 1 | Hypertension |
| 125527111 | 12552711 | 3 | Hyperlipidaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125527111 | 12552711 | Dizziness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125527111 | 12552711 | 1 | 2010 | 20160216 | 0 | |
| 125527111 | 12552711 | 2 | 20160217 | 20160503 | 0 | |
| 125527111 | 12552711 | 3 | 2010 | 0 |